Aescin (Reparil) versus Ibuprofen for pain, swelling, and limited mouth opening after impacted lower wisdom tooth removal
Official title: Evaluation of Aescin-Based Herbal Extracts for Managing Postoperative Sequelae Following Impacted Mandibular Third Molar Surgery: A Randomized, Single-Blind, Controlled Trial
Run by Oman Medical Speciality Board · NCT07244029 · Data updated 2026-11-12
We will test whether Reparil (aescin) works as well as ibuprofen to reduce pain, swelling, and jaw stiffness after impacted lower wisdom tooth removal in adults aged 18-40.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Oman Medical Speciality Board Government |
| Locations | 1 site (Muscat, Al Khoud) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | October 20, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT07244029 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-40 who are ASA I-II and scheduled for surgical removal of similarly positioned impacted mandibular third molars with comparable difficulty scores are ideal candidates.
✕Probably not a fit
Patients with contraindications to NSAIDs, known allergies to aescin or ibuprofen, pregnant or lactating women, recent use of anti-inflammatories/corticosteroids/antibiotics, or those with significant systemic disease may not benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, randomized, single-blind trial enrolling 100 adults who need surgical removal of impacted mandibular third molars at a dental center in Muscat, Oman. Participants are randomly assigned to Reparil (aescin 20 mg three times daily) or ibuprofen (400 mg three times daily) for five days after a standardized extraction. Outcomes include patient-reported pain (VAS), objective facial swelling measured with a 3D facial scanner, and mouth opening measured with a digital caliper, recorded preoperatively, on day 2, and on day 7 post-surgery. The study also monitors adverse events to compare safety profiles between the herbal extract and the NSAID.
Why it matters
Potential benefit: If successful, Reparil could provide similar pain and swelling relief to ibuprofen while reducing NSAID-related side effects.
How similar studies have gone: Aescin has shown clinical benefit for soft-tissue edema and venous disorders in other settings, but its use specifically after oral surgical extractions is novel and not extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients indicated for surgical removal of impacted mandibular third molars according to National Institute for Health and Care Excellence (NICE) guidelines. Age between 18 and 40 years. Impacted mandibular third molars with similar anatomical position and difficulty level as classified by Pell and Gregory and Pederson scoring. Healthy individuals (ASA I-II) with no significant systemic illness. Willing to provide written informed consent and attend all follow-up visits (Day 2 and Day 7 post-surgery). Exclusion Criteria: * Recent use (within three weeks preoperatively) of anti-inflammatories, corticosteroids, or antibiotics. Known allergies or hypersensitivity to Aescin, Ibuprofen, rescue medications, or local anesthetics. Pregnant or lactating women. Patients with contraindications to NSAIDs (e.g., asthma, bleeding disorders, chronic kidney disease, active peptic ulcer, or cardiovascular disease). Recent use of substances that may affect surgery or interact with study drugs (e.g., contraceptives, alcohol, or tobacco). Surgical time exceeding 30 minutes or cases with intraoperative complications requiring non-study medications.
Where it's running
-
Medical City for Military and Security Services - Dental Center
Muscat, Al Khoud, Oman Recruiting
Study contacts
- Principal investigator: Suhail H AL Samari, BDS, MFD — Oman Medical Speciality Board
- Study coordinator: Suhail H AlSamari, BDS, MFD
- Email: suhail.dental@gmail.com
- Phone: +968 97366511
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tea tree oil versus chlorhexidine mouthwash after impacted lower wisdom tooth removal
This tests whether tea tree oil mouthwash can reduce swelling, pain, limited mouth opening, and help gum healing as well as standard chlorhexidine in adults after extraction of impacted lower wisdom teeth.
-
Hilotherapy versus Kinesio taping for recovery after bimaxillary jaw surgery
This study will test whether kinesio taping or hilotherapy reduces swelling, pain, and limited mouth opening in adults after bimaxillary orthognathic (jaw) surgery.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
Palatal Shield Technique to Reduce Pain and Improve Healing After Free Gingival Graft
This randomized trial tests whether a collagen sponge with a protective palatal shield made of flowable resin helps reduce pain and improve healing after free gingival graft harvest.
-
Perfusion Index to Measure Postoperative Pain in Kids After Adenotonsillectomy
This study tests whether the perfusion index can reliably reflect pain levels in children aged 1–12 after adenotonsillectomy, comparing standard care with an added glossopharyngeal nerve block.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.